MLH1 and cancer: This makes it difficult to conclude whether NDR-acquiring CGI promoters are more likely to be the result of a cis versus trans mechanism, but this question is central to understanding how CGI promoters for cancer driver genes like MLH1, BRCA1, and VHL become epigenetically silenced in cancer.